SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Lawrence Serfaty, Is there still a role for PEG IFN+RBV therapy in patients with HCV genotype 1?, Liver International, 2014, 34,
  2. 2
    Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Pegylated interferon and ribavirin: a therapeutic option in patients who fail to respond to telaprevir-based triple therapy?, Hepatology, 2013, 58, 4
  3. 3
    Telaprevir, Reactions Weekly, 2013, 1466, 1, 40

    CrossRef